Browse All

Current Filters

CLEAR FILTER x

TITLE

Author Institution:

Extended Interval Dosing of Ocrelizumab in Patients with Multiple Sclerosis Is Not Associated with Meaningful Differences in Disease Activity

Author:Bou Rjeily, Nicole   Fitzgerald, Kathryn   Mowry, Ellen   

Session Name:P14: MS Clinical Practice  

Topic:MS and Inflammatory Disease  

Program Number:P14.010  

Author Institution:Johns Hopkins University, Baltimore, MD